<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Seo D</submitter><funding>National Research Foundation of Korea</funding><pagination>2071-2078</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9708433</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>36(6)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Serum uromodulin concentration has been described as a novel biomarker of chronic kidney disease (CKD) in humans but not dogs.&lt;h4>Objective&lt;/h4>To evaluate the serum uromodulin concentration in dogs with CKD and assess its diagnostic performance in distinguishing dogs with CKD from healthy dogs.&lt;h4>Animals&lt;/h4>Forty-nine dogs with CKD (International Renal Interest Society [IRIS] Stage 1, n = 23; Stage 2, n = 20; Stage 3-4, n = 6) and 25 healthy controls.&lt;h4>Methods&lt;/h4>Prospective, observational study. Serum uromodulin concentration was measured using a canine-specific enzyme-linked immunosorbent assay (ELISA), and its correlation with conventional renal markers was analyzed.&lt;h4>Results&lt;/h4>Serum uromodulin concentrations were significantly lower in the CKD group than in the control group (P &lt; .001), but no significant difference was observed among stages of CKD. A negative correlation was observed between serum uromodulin concentration and conventional renal markers (blood urea nitrogen concentration, r = -.60, P &lt; .0001; serum creatinine concentration, r = -.46, P &lt; .0001; serum symmetric dimethylarginine concentration [SDMA], r = -.65, P &lt; .0001). In receiver operating characteristic analysis, the area under the curve (AUC) of uromodulin (AUC, 0.97; 95% confidence interval [CI], 0.94-1.00) was higher than that of SDMA (AUC, 0.87; 95% CI, 0.79-0.95) for CKD diagnosis (P = .01). The AUC of uromodulin (AUC, 0.95; 95% CI, 0.89-1.00) also was higher than that of SDMA (AUC, 0.72; 95% CI, 0.58-0.87) in distinguishing dogs with Stage 1 CKD from controls (P = .001).&lt;h4>Conclusions and clinical importance&lt;/h4>Serum uromodulin concentration is decreased in dogs with CKD. Thus, serum uromodulin may be a valuable diagnostic marker for CKD in dogs, particularly in identifying early-stage CKD.</pubmed_abstract><journal>Journal of veterinary internal medicine</journal><pubmed_title>Serum uromodulin in dogs with chronic kidney disease.</pubmed_title><pmcid>PMC9708433</pmcid><funding_grant_id>NRF-2020R1A2C1010215</funding_grant_id><funding_grant_id>NRF‐2020R1A2C1010215</funding_grant_id><pubmed_authors>Seo D</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Choi G</pubmed_authors><pubmed_authors>Hwang SH</pubmed_authors><pubmed_authors>Kim Y</pubmed_authors><pubmed_authors>Jung JH</pubmed_authors><pubmed_authors>Cho S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Serum uromodulin in dogs with chronic kidney disease.</name><description>&lt;h4>Background&lt;/h4>Serum uromodulin concentration has been described as a novel biomarker of chronic kidney disease (CKD) in humans but not dogs.&lt;h4>Objective&lt;/h4>To evaluate the serum uromodulin concentration in dogs with CKD and assess its diagnostic performance in distinguishing dogs with CKD from healthy dogs.&lt;h4>Animals&lt;/h4>Forty-nine dogs with CKD (International Renal Interest Society [IRIS] Stage 1, n = 23; Stage 2, n = 20; Stage 3-4, n = 6) and 25 healthy controls.&lt;h4>Methods&lt;/h4>Prospective, observational study. Serum uromodulin concentration was measured using a canine-specific enzyme-linked immunosorbent assay (ELISA), and its correlation with conventional renal markers was analyzed.&lt;h4>Results&lt;/h4>Serum uromodulin concentrations were significantly lower in the CKD group than in the control group (P &lt; .001), but no significant difference was observed among stages of CKD. A negative correlation was observed between serum uromodulin concentration and conventional renal markers (blood urea nitrogen concentration, r = -.60, P &lt; .0001; serum creatinine concentration, r = -.46, P &lt; .0001; serum symmetric dimethylarginine concentration [SDMA], r = -.65, P &lt; .0001). In receiver operating characteristic analysis, the area under the curve (AUC) of uromodulin (AUC, 0.97; 95% confidence interval [CI], 0.94-1.00) was higher than that of SDMA (AUC, 0.87; 95% CI, 0.79-0.95) for CKD diagnosis (P = .01). The AUC of uromodulin (AUC, 0.95; 95% CI, 0.89-1.00) also was higher than that of SDMA (AUC, 0.72; 95% CI, 0.58-0.87) in distinguishing dogs with Stage 1 CKD from controls (P = .001).&lt;h4>Conclusions and clinical importance&lt;/h4>Serum uromodulin concentration is decreased in dogs with CKD. Thus, serum uromodulin may be a valuable diagnostic marker for CKD in dogs, particularly in identifying early-stage CKD.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2026-06-20T03:13:01.505Z</modification><creation>2026-06-20T03:10:51.649Z</creation></dates><accession>S-EPMC9708433</accession><cross_references><pubmed>36330885</pubmed><doi>10.1111/jvim.16579</doi></cross_references></HashMap>